GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius SE & Co KGaA (OTCPK:FSNUY) » Definitions » Cyclically Adjusted Revenue per Share

FSNUY (Fresenius SE KGaA) Cyclically Adjusted Revenue per Share : $17.79 (As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is Fresenius SE KGaA Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Fresenius SE KGaA's adjusted revenue per share for the three months ended in Mar. 2025 was $2.712. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $17.79 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Fresenius SE KGaA's average Cyclically Adjusted Revenue Growth Rate was -0.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 6.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Fresenius SE KGaA was 8.60% per year. The lowest was 4.10% per year. And the median was 7.50% per year.

As of today (2025-05-16), Fresenius SE KGaA's current stock price is $12.11. Fresenius SE KGaA's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was $17.79. Fresenius SE KGaA's Cyclically Adjusted PS Ratio of today is 0.68.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Fresenius SE KGaA was 1.91. The lowest was 0.32. And the median was 0.73.


Fresenius SE KGaA Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Fresenius SE KGaA's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius SE KGaA Cyclically Adjusted Revenue per Share Chart

Fresenius SE KGaA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.10 16.27 16.89 17.85 16.97

Fresenius SE KGaA Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.68 17.64 18.23 16.97 17.79

Competitive Comparison of Fresenius SE KGaA's Cyclically Adjusted Revenue per Share

For the Medical Care Facilities subindustry, Fresenius SE KGaA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius SE KGaA's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Fresenius SE KGaA's Cyclically Adjusted PS Ratio falls into.


;
;

Fresenius SE KGaA Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Fresenius SE KGaA's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=2.712/127.7792*127.7792
=2.712

Current CPI (Mar. 2025) = 127.7792.

Fresenius SE KGaA Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 3.532 100.417 4.494
201509 3.539 100.417 4.503
201512 3.594 99.717 4.605
201603 3.544 100.017 4.528
201606 3.687 100.717 4.678
201609 3.760 101.017 4.756
201612 3.739 101.217 4.720
201703 4.000 101.417 5.040
201706 4.306 102.117 5.388
201709 4.425 102.717 5.505
201712 4.606 102.617 5.735
201803 4.483 102.917 5.566
201806 4.385 104.017 5.387
201809 4.270 104.718 5.210
201812 4.501 104.217 5.519
201903 4.298 104.217 5.270
201906 4.458 105.718 5.388
201909 4.324 106.018 5.212
201912 4.629 105.818 5.590
202003 4.519 105.718 5.462
202006 4.513 106.618 5.409
202009 4.702 105.818 5.678
202012 5.066 105.518 6.135
202103 4.786 107.518 5.688
202106 4.993 108.486 5.881
202109 4.914 109.435 5.738
202112 5.041 110.384 5.835
202203 4.792 113.968 5.373
202206 4.700 115.760 5.188
202209 2.367 118.818 2.546
202212 2.666 119.345 2.854
202303 2.636 122.402 2.752
202306 2.522 123.140 2.617
202309 2.457 124.195 2.528
202312 2.602 123.773 2.686
202403 2.581 125.038 2.638
202406 2.600 125.882 2.639
202409 2.649 126.198 2.682
202412 2.617 127.041 2.632
202503 2.712 127.779 2.712

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Fresenius SE KGaA  (OTCPK:FSNUY) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Fresenius SE KGaA's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=12.11/17.79
=0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Fresenius SE KGaA was 1.91. The lowest was 0.32. And the median was 0.73.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Fresenius SE KGaA Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Fresenius SE KGaA's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Fresenius SE KGaA Business Description

Address
Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius SE is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.